Impact of EGFR exon 19 deletion subtypes on clinical outcomes in EGFR-TKI-Treated advanced non-small-cell lung cancer.

Huang, Le-Tian; Zhang, Shu-Ling; Han, Cheng-Bo; Ma, Jie-Tao

Huang, Le-Tian; Zhang, Shu-Ling; Han, Cheng-Bo; Ma, Jie-Tao.

Afiliación

Huang LT; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China.
Zhang SL; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China.
Han CB; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China.
Ma JT; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110022, China. Electronic address: majt@sj-hospital.org.

Lung Cancer ; 166: 9-16, 2022 04.

Article en En | MEDLINE | ID: mdl-35151115

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Neoplasias Pulmonares; Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico; Carcinoma de Pulmón de Células no Pequeñas/genética; Receptores ErbB/genética; Exones; Humanos; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/genética; Mutación; Estudios Prospectivos; Inhibidores de Proteínas Quinasas/uso terapéutico; Estudios Retrospectivos

Palabras clave

EGFR; Exon 19 deletion subtypes; Meta-analysis; Non-small cell lung cancer; Target therapy; Tyrosine kinase inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google